Activation of Akt1 has been detected in approximately half of pancreatic ductal adenocarcinoma cancer patients [20], and it appears to exert its oncogenic activity in this cancer by overcoming cell cycle arrest, [21, 22] blocking apoptosis [23, 24], and promoting angiogenesis [25]. Here, AKT1 is linked to cancer.